Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine
Clinical trial NCT04608305 · COMPLETED
Trial details
- NCT number
- NCT04608305
- Sponsor
- Israel Institute for Biological Research (IIBR)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-28
- Primary completion
- 2022-10-03
- Enrollment
- 843
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.